Orca Bio is a pioneering brand that is revolutionizing the field of cell therapies. With a mission to expand the life-changing benefits of these therapies, Orca Bio is developing next-generation cell therapies that aim to significantly improve survival rates while minimizing risks. Their purified, high-precision investigational cell therapies not only aim to replace patients' blood and immune systems with healthy ones but also to restore their lives.

Founded in 2016 by visionary leaders in the stem cell field, Orca Bio is committed to pushing past the current limitations in transplant processes. They combine proven scientific insights with a cutting-edge cell-sorting platform to deliver purified, high-precision investigational cell therapies to patients. At Orca Bio, patients come first, and the brand continuously works to ensure that they don't have to settle for anything less.

The leadership team, which includes industry veterans and company founders, is focused on redefining the future of cell therapies for the betterment of patients. With their expertise and dedication, they are transforming the way we approach blood diseases and severe autoimmune diseases, offering hope for a longer and better quality of life. Orca Bio's innovative research approach and commitment to improving clinical outcomes make them a leading brand in the field of cell therapies.

Their team of experts, including medical professionals and scientists, are working diligently to develop life-changing therapies that have the potential to eradicate diseases and provide patients with a brighter future